PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24716934-1 2014 PURPOSE: To assess the effect and safety of lobaplatin combinated floxuridine /pirarubicin in transcatheter hepatic arterial chemoembolization(TACE) of unresectable primary liver cancer. Floxuridine 66-77 ADAM metallopeptidase domain 17 Homo sapiens 143-147